Healthcare provider profile · identity verified

Elizabeth Cooley, MD

Family Practice · UTICA, NY · NPI 1871748020

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	117
Levothyroxine Sodium	Levothyroxine Sodium	397	76
Amlodipine Besylate	Amlodipine Besylate	230	66
Omeprazole	Omeprazole	224	57
Lisinopril	Lisinopril	217	64
Furosemide	Furosemide	207	41
Losartan Potassium	Losartan Potassium	188	37
Sertraline Hcl	Sertraline Hcl	173	36
Gabapentin	Gabapentin	167	36
Metformin Hcl	Metformin Hcl	162	43
Eliquis	Apixaban	148	22
Pantoprazole Sodium	Pantoprazole Sodium	143	42
Metoprolol Succinate	Metoprolol Succinate	133	40
Tamsulosin Hcl	Tamsulosin Hcl	127	24
Rosuvastatin Calcium	Rosuvastatin Calcium	123	27
Metoprolol Tartrate	Metoprolol Tartrate	114	29
Trazodone Hcl	Trazodone Hcl	109	19
Montelukast Sodium	Montelukast Sodium	108	30
Buspirone Hcl	Buspirone Hcl	92	26
Clopidogrel	Clopidogrel Bisulfate	92	23
Escitalopram Oxalate	Escitalopram Oxalate	91	24
Simvastatin	Simvastatin	89	25
Albuterol Sulfate Hfa	Albuterol Sulfate	86	45
Duloxetine Hcl	Duloxetine Hcl	85	20
Levetiracetam	Levetiracetam	79	12
Fluoxetine Hcl	Fluoxetine Hcl	76	14
Famotidine	Famotidine	74	25
Potassium Chloride	Potassium Chloride	70	17
Ramipril	Ramipril	68	11
Alprazolam	Alprazolam	67	20
Bisoprolol Fumarate	Bisoprolol Fumarate	65	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	13
Memantine Hcl	Memantine Hcl	65	suppressed
Meloxicam	Meloxicam	62	24
Metformin Hcl Er	Metformin Hcl	58	16
Atenolol	Atenolol	57	12
Baclofen	Baclofen	57	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	53	14
Glipizide	Glipizide	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	50	11
Carvedilol	Carvedilol	49	12
Januvia	Sitagliptin Phosphate	48	12
Sucralfate	Sucralfate	48	suppressed
Donepezil Hcl	Donepezil Hcl	47	11
Olanzapine	Olanzapine	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	14
Mirtazapine	Mirtazapine	45	13
Fluticasone Propionate	Fluticasone Propionate	44	18
Glipizide Er	Glipizide	44	12
Hydralazine Hcl	Hydralazine Hcl	44	13
Torsemide	Torsemide	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Divalproex Sodium	Divalproex Sodium	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Lamotrigine	Lamotrigine	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Jardiance	Empagliflozin	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Glimepiride	Glimepiride	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Amoxicillin	Amoxicillin	32	31
Finasteride	Finasteride	32	11
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Cephalexin	Cephalexin	30	28
Prednisone	Prednisone	28	21
Midodrine Hcl	Midodrine Hcl	27	suppressed
Fluconazole	Fluconazole	26	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Ozempic	Semaglutide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Klor-Con M10	Potassium Chloride	24	suppressed
Methylprednisolone	Methylprednisolone	24	23
Pilocarpine Hcl	Pilocarpine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Rexulti	Brexpiprazole	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Constulose	Lactulose	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Linzess	Linaclotide	19	suppressed
Azithromycin	Azithromycin	18	14
Clonidine Hcl	Clonidine Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Risperidone	Risperidone	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Topiramate	Topiramate	16	suppressed
Acetic Acid	Acetic Acid	15	suppressed
Lactulose	Lactulose	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nystatin	Nystatin	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	14	14
Phenobarbital	Phenobarbital	14	suppressed
Primidone	Primidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Metolazone	Metolazone	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nyamyc	Nystatin	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Valsartan	Valsartan	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Naproxen	Naproxen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error